Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI
Nanomaterials · 27.01.2023 · 13 (3) · 503
DOI: 10.3390/nano13030503 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 27.01.2023. Verfasst von Maria-Argyro Karageorgou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, National and Kapodistrian University of Athens, 15784 Athens, Greece. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
During the last decades, the utilization of imaging modalities such as single photon emission computed tomography (SPECT), positron emission tomography (PET), and magnetic resonance imaging (MRI) in every day clinical practice has enabled clinicians to diagnose diseases accurately at early stages. Radiolabeled iron oxide nanoparticles (RIONs) combine their intrinsic magnetic behavior with the extrinsic character of the radionuclide additive, so that they constitute a platform of multifaceted physical properties. Thus, at a practical level, RIONs serve as the physical parent of the so-called dual-modality contrast agents (DMCAs) utilized in SPECT/MRI and PET/MRI applications due to their ability to combine, at real time, the high sensitivity of SPECT or PET together with the high spatial resolution of MRI. This review focuses on the synthesis and in vivo investigation of both biodistribution and imaging efficacy of RIONs as potential SPECT/MRI or PET/MRI DMCAs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physics, National and Kapodistrian University of Athens, 15784 Athens, Greece.
- Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center for Scientific Research "Demokritos", 15341 Athens, Greece.
- Institute of Nanoscience & Nanotechnology, National Center for Scientific Research "Demokritos", 15341 Athens, Greece.
ORCID-Profile: Maria-Argyro Karageorgou, Penelope Bouziotis
Zitieren
APA
Karageorgou, M. A., Bouziotis, P., Stiliaris, E., & Stamopoulos, D. (2023). Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI. Nanomaterials, 13(3), 503. https://doi.org/10.3390/nano13030503
Vancouver
Karageorgou MA, Bouziotis P, Stiliaris E, Stamopoulos D. Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI. Nanomaterials. 2023;13(3):503. doi:10.3390/nano13030503
BibTeX
@article{Karageorgou2023,
author = {Karageorgou, Maria-Argyro and Bouziotis, Penelope and Stiliaris, Efstathios and Stamopoulos, Dimosthenis},
title = {Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI},
journal = {Nanomaterials},
year = {2023},
volume = {13},
number = {3},
pages = {503},
doi = {10.3390/nano13030503}
}
EUVIMED